Literature DB >> 1471862

Multiple sclerosis in 54 twinships: concordance rate is independent of zygosity. French Research Group on Multiple Sclerosis.

.   

Abstract

In a large population-based multiple sclerosis (MS) sample (n = 7,951), 116 twins were identified (1.4%), of which it was possible to contact 97. In 27 pairs, the twin of the patient with MS was dead. Among the 70 remaining pairs, 16 were excluded because either the index patient or their twin did not accept protocol requirements. The final sample included 54 pairs. Twin zygosity was determined by DNA fingerprint analysis. We found 17 monozygotic pairs and 37 dizygotic pairs. One of the 17 monozygotic pairs (5.9%) and 1 of the 37 dizygotic pairs (2.7%) were concordant for MS. In 42 of the clinically unaffected twins, magnetic resonance imaging (MRI) of the brain was performed, and 9 scans were classified as indicative of MS. Three of these 42 patients had abnormal visual-evoked potentials, but all 3 had normal MRI scans. The overall proportion of pairs in which the co-twin had some form of clinical, radiological, or electrophysiological abnormality was approximately 30%; this proportion was independent of zygosity.

Entities:  

Mesh:

Year:  1992        PMID: 1471862     DOI: 10.1002/ana.410320604

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

Review 1.  Genetic analysis of multiple sclerosis.

Authors:  Alastair Compston; Stephen Sawcer
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

Review 2.  The therapeutic potential of epigenetics in autoimmune diseases.

Authors:  Maria De Santis; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

3.  Twin concordance and sibling recurrence rates in multiple sclerosis.

Authors:  C J Willer; D A Dyment; N J Risch; A D Sadovnick; G C Ebers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

Review 4.  Pharmacological treatment of early multiple sclerosis.

Authors:  Olaf Stüve; Jeffrey L Bennett; Bernhard Hemmer; Heinz Wiendl; Michael K Racke; Amit Bar-Or; Wei Hu; Robert Zivadinov; Martin S Weber; Scott S Zamvil; Maria F Pacheco; Til Menge; Hans-Peter Hartung; Bernd C Kieseier; Elliot M Frohman
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  British Isles survey of multiple sclerosis in twins: MRI.

Authors:  J W Thorpe; C J Mumford; D A Compston; B E Kendall; D G MacManus; W I McDonald; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

6.  TCRB-V gene usage in monozygotic twins discordant for multiple sclerosis.

Authors:  M P Roth; J Riond; E Champagne; S Essaket; A Cambon-Thomsen; J Clayton; M Clanet; H Coppin
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

Review 7.  Epigenetic changes in patients with multiple sclerosis.

Authors:  Marcus W Koch; Luanne M Metz; Olga Kovalchuk
Journal:  Nat Rev Neurol       Date:  2012-11-20       Impact factor: 42.937

8.  Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.

Authors:  Sergio E Baranzini; Joann Mudge; Jennifer C van Velkinburgh; Pouya Khankhanian; Irina Khrebtukova; Neil A Miller; Lu Zhang; Andrew D Farmer; Callum J Bell; Ryan W Kim; Gregory D May; Jimmy E Woodward; Stacy J Caillier; Joseph P McElroy; Refujia Gomez; Marcelo J Pando; Leonda E Clendenen; Elena E Ganusova; Faye D Schilkey; Thiruvarangan Ramaraj; Omar A Khan; Jim J Huntley; Shujun Luo; Pui-Yan Kwok; Thomas D Wu; Gary P Schroth; Jorge R Oksenberg; Stephen L Hauser; Stephen F Kingsmore
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

Review 9.  Disease-modifying agents for multiple sclerosis: recent advances and future prospects.

Authors:  Til Menge; Martin S Weber; Bernhard Hemmer; Bernd C Kieseier; Hans-Christian von Büdingen; Clemens Warnke; Scott S Zamvil; Aaron Boster; Omar Khan; Hans-Peter Hartung; Olaf Stüve
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  The causal cascade to multiple sclerosis: a model for MS pathogenesis.

Authors:  Douglas S Goodin
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.